Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution
- PMID: 17125906
- DOI: 10.1016/j.eururo.2006.11.023
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution
Abstract
Objectives: To investigate the feasibility of thermotherapy using biocompatible superparamagnetic nanoparticles in patients with locally recurrent prostate cancer and to evaluate an imaging-based approach for noninvasive calculations of the three-dimensional temperature distribution.
Methods: Ten patients with locally recurrent prostate cancer following primary therapy with curative intent were entered into a prospective phase 1 trial. The magnetic fluid was injected transperineally into the prostates according to a preplan. Patients received six thermal therapies of 60-min duration at weekly intervals using an alternating magnetic field applicator. A method of three-dimensional thermal analysis based on computed tomography (CT) of the prostates was developed and correlated with invasive and intraluminal temperature measurements. The sensitivity of nanoparticle detection by means of CT was investigated in phantoms.
Results: The median detection rate of iron oxide nanoparticles in tissue specimens using CT was 89.5% (range: 70-98%). Maximum temperatures up to 55 degrees C were achieved in the prostates. Median temperatures in 20%, 50%, and 90% of the prostates were 41.1 degrees C (range: 40.0-47.4 degrees C), 40.8 degrees C (range: 39.5-45.4 degrees C), and 40.1 degrees C (range: 38.8-43.4 degrees C), respectively. Median urethral and rectal temperatures were 40.5 degrees C (range: 38.4-43.6 degrees C) and 39.8 degrees C (range: 38.2-43.4 degrees C). The median thermal dose was 7.8 (range: 3.5-136.4) cumulative equivalent minutes at 43 degrees C in 90% of the prostates.
Conclusion: The heating technique using magnetic nanoparticles was feasible. Hyperthermic to thermoablative temperatures were achieved in the prostates at 25% of the available magnetic field strength, indicating a significant potential for higher temperatures. A noninvasive thermometry method specific for this approach could be developed, which may be used for thermal dosimetry in future studies.
Comment in
-
Editorial comment on: Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.Eur Urol. 2007 Dec;52(6):1661-2. Eur Urol. 2007. PMID: 18074432 No abstract available.
Similar articles
-
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.Int J Hyperthermia. 2007 May;23(3):315-23. doi: 10.1080/02656730601175479. Int J Hyperthermia. 2007. PMID: 17523023 Clinical Trial.
-
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.Int J Hyperthermia. 2005 Nov;21(7):637-47. doi: 10.1080/02656730500158360. Int J Hyperthermia. 2005. PMID: 16304715
-
Editorial comment on: Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.Eur Urol. 2007 Dec;52(6):1661-2. Eur Urol. 2007. PMID: 18074432 No abstract available.
-
Magnetic nanoparticle hyperthermia for prostate cancer.Int J Hyperthermia. 2010;26(8):790-5. doi: 10.3109/02656731003745740. Epub 2010 Jul 23. Int J Hyperthermia. 2010. PMID: 20653418 Review.
-
[Thermal therapy of prostate cancer using magnetic nanoparticles].Actas Urol Esp. 2007 Jun;31(6):660-7. doi: 10.1016/s0210-4806(07)73703-8. Actas Urol Esp. 2007. PMID: 17896563 Review. Spanish.
Cited by
-
Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.Int J Nanomedicine. 2021 Apr 23;16:2965-2981. doi: 10.2147/IJN.S288379. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33935496 Free PMC article.
-
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.Adv Drug Deliv Rev. 2020;163-164:65-83. doi: 10.1016/j.addr.2020.06.025. Epub 2020 Jun 27. Adv Drug Deliv Rev. 2020. PMID: 32603814 Free PMC article.
-
Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality.Sci Rep. 2018 Aug 23;8(1):12706. doi: 10.1038/s41598-018-29711-0. Sci Rep. 2018. PMID: 30139940 Free PMC article.
-
Systemic Administration of Polyelectrolyte Microcapsules: Where Do They Accumulate and When? In Vivo and Ex Vivo Study.Nanomaterials (Basel). 2018 Oct 10;8(10):812. doi: 10.3390/nano8100812. Nanomaterials (Basel). 2018. PMID: 30308931 Free PMC article.
-
PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications.Front Bioeng Biotechnol. 2020 May 5;8:381. doi: 10.3389/fbioe.2020.00381. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32432092 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical